Abstract
Background National governments have implemented non-pharmaceutical interventions to control and mitigate against the COVID-19 pandemic. A deep understanding of these interventions is required.
Objective We investigate the prediction of future daily national Confirmed Infection Growths – the percentage change in total cumulative cases across 14 days – using metrics representative of non-pharmaceutical interventions and cultural dimensions of each country.
Methods We combine the OxCGRT dataset, Hofstede’s cultural dimensions, and COVID-19 daily reported infection case numbers to train and evaluate five non-time series machine learning models in predicting Confirmed Infection Growth. We use three validation methods – in-distribution, out-of-distribution, and country-based cross-validation – for evaluation, each applicable to a different use case of the models.
Results Our results demonstrate high R2 values between the labels and predictions for the in-distribution, out-of-distribution, and country-based cross-validation methods (0.959, 0.513, and 0.574 respectively) using random forest and AdaBoost regression. While these models may be used to predict the Confirmed Infection Growth, the differing accuracies obtained from the three tasks suggest a strong influence of the use case.
Conclusions This work provides new considerations in using machine learning techniques with non-pharmaceutical interventions and cultural dimensions data for predicting the national growth of confirmed infections of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding supported the work presented.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study does not require an IRB/ethics committee approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this manuscript is open-sourced and readily accessible online.
